Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Ptpn11 deletion in a novel progenitor causes metachondromatosis by inducing hedgehog signalling

A Corrigendum to this article was published on 16 April 2014

This article has been updated

Abstract

The tyrosine phosphatase SHP2, encoded by PTPN11, is required for the survival, proliferation and differentiation of various cell types1,2. Germline activating mutations in PTPN11 cause Noonan syndrome, whereas somatic PTPN11 mutations cause childhood myeloproliferative disease and contribute to some solid tumours. Recently, heterozygous inactivating mutations in PTPN11 were found in metachondromatosis, a rare inherited disorder featuring multiple exostoses, enchondromas, joint destruction and bony deformities3,4. The detailed pathogenesis of this disorder has remained unclear. Here we use a conditional knockout (floxed) Ptpn11 allele (Ptpn11fl) and Cre recombinase transgenic mice to delete Ptpn11 specifically in monocytes, macrophages and osteoclasts (lysozyme M-Cre; LysMCre) or in cathepsin K (Ctsk)-expressing cells, previously thought to be osteoclasts. LysMCre;Ptpn11fl/fl mice had mild osteopetrosis. Notably, however, CtskCre;Ptpn11fl/fl mice developed features very similar to metachondromatosis. Lineage tracing revealed a novel population of CtskCre-expressing cells in the perichondrial groove of Ranvier that display markers and functional properties consistent with mesenchymal progenitors. Chondroid neoplasms arise from these cells and show decreased extracellular signal-regulated kinase (ERK) pathway activation, increased Indian hedgehog (Ihh) and parathyroid hormone-related protein (Pthrp, also known as Pthlh) expression and excessive proliferation. Shp2-deficient chondroprogenitors had decreased fibroblast growth factor-evoked ERK activation and enhanced Ihh and Pthrp expression, whereas fibroblast growth factor receptor (FGFR) or mitogen-activated protein kinase kinase (MEK) inhibitor treatment of chondroid cells increased Ihh and Pthrp expression. Importantly, smoothened inhibitor treatment ameliorated metachondromatosis features in CtskCre;Ptpn11fl/fl mice. Thus, in contrast to its pro-oncogenic role in haematopoietic and epithelial cells, Ptpn11 is a tumour suppressor in cartilage, acting through a FGFR/MEK/ERK-dependent pathway in a novel progenitor cell population to prevent excessive Ihh production.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Ptpn11 deletion in Ctsk-expressing cells causes metachondromatosis.
Figure 2: Skeletal tumours in Ctsk-KO mice originate from perichondrial groove of Ranvier cells.
Figure 3: Ptpn11 deletion in Ctsk-expressing cells causes expansion of novel chondroprogenitor cell population within the perichondrial groove of Ranvier.
Figure 4: Shp2 deficiency impairs Erk activation but promotes Ihh and Pthrp expression.

Similar content being viewed by others

Change history

References

  1. Neel, B. G., Chan, G. & Dhanji, S. in Handbook of Cell Signaling Vol. 2 (eds Bradshaw, R. A. & Dennis, E. A. ) Ch. 98, 771–809 (2009)

  2. Grossmann, K. S., Rosario, M., Birchmeier, C. & Birchmeier, W. The tyrosine phosphatase Shp2 in development and cancer. Adv. Cancer Res. 106, 53–89 (2010)

    Article  CAS  Google Scholar 

  3. Bowen, M. E. et al. Loss-of-function mutations in PTPN11 cause metachondromatosis, but not Ollier disease or Maffucci syndrome. PLoS Genet. 7, e1002050 (2011)

    Article  CAS  Google Scholar 

  4. Sobreira, N. L. et al. Whole-genome sequencing of a single proband together with linkage analysis identifies a Mendelian disease gene. PLoS Genet. 6, e1000991 (2010)

    Article  Google Scholar 

  5. Bovée, J. V., Hogendoorn, P. C., Wunder, J. S. & Alman, B. A. Cartilage tumours and bone development: molecular pathology and possible therapeutic targets. Nature Rev. Cancer 10, 481–488 (2010)

    Article  Google Scholar 

  6. Pannier, S. & Legeai-Mallet, L. Hereditary multiple exostoses and enchondromatosis. Best Pract. Res. Clin. Rheumatol. 22, 45–54 (2008)

    Article  CAS  Google Scholar 

  7. Pansuriya, T. C., Kroon, H. M. & Bovee, J. V. Enchondromatosis: insights on the different subtypes. Int. J. Clin. Exp. Pathol. 3, 557–569 (2010)

    PubMed  PubMed Central  Google Scholar 

  8. Tartaglia, M., Gelb, B. D. & Zenker, M. Noonan syndrome and clinically related disorders. Best Pract. Res. Clin. Endocrinol. Metab. 25, 161–179 (2011)

    Article  CAS  Google Scholar 

  9. Saxton, T. M. et al. Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2. EMBO J. 16, 2352–2364 (1997)

    Article  CAS  Google Scholar 

  10. Yang, W. et al. An Shp2/SFK/Ras/Erk signaling pathway controls trophoblast stem cell survival. Dev. Cell 10, 317–327 (2006)

    Article  CAS  Google Scholar 

  11. Clausen, B. E., Burkhardt, C., Reith, W., Renkawitz, R. & Forster, I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8, 265–277 (1999)

    Article  CAS  Google Scholar 

  12. Nakamura, T. et al. Estrogen prevents bone loss via estrogen receptor α and induction of Fas ligand in osteoclasts. Cell 130, 811–823 (2007)

    Article  CAS  Google Scholar 

  13. Dodds, R. A., Connor, J. R., Drake, F., Feild, J. & Gowen, M. Cathepsin K mRNA detection is restricted to osteoclasts during fetal mouse development. J. Bone Miner. Res. 13, 673–682 (1998)

    Article  CAS  Google Scholar 

  14. Langenskiöld, A. Role of the ossification groove of Ranvier in normal and pathologic bone growth: a review. J. Pediatr. Orthop. 18, 173–177 (1998)

    PubMed  Google Scholar 

  15. Shapiro, F., Holtrop, M. E. & Glimcher, M. J. Organization and cellular biology of the perichondrial ossification groove of ranvier: a morphological study in rabbits. J. Bone Joint Surg. Am. 59, 703–723 (1977)

    Article  CAS  Google Scholar 

  16. Karlsson, C., Thornemo, M., Henriksson, H. B. & Lindahl, A. Identification of a stem cell niche in the zone of Ranvier within the knee joint. J. Anat. 215, 355–363 (2009)

    Article  Google Scholar 

  17. Goldring, M. B., Tsuchimochi, K. & Ijiri, K. The control of chondrogenesis. J. Cell. Biochem. 97, 33–44 (2006)

    Article  CAS  Google Scholar 

  18. Hopyan, S. et al. A mutant PTH/PTHrP type I receptor in enchondromatosis. Nature Genet. 30, 306–310 (2002)

    Article  Google Scholar 

  19. Tiet, T. D. et al. Constitutive Hedgehog signaling in chondrosarcoma up-regulates tumor cell proliferation. Am. J. Pathol. 168, 321–330 (2006)

    Article  CAS  Google Scholar 

  20. Liu, Z., Xu, J., Colvin, J. S. & Ornitz, D. M. Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18. Genes Dev. 16, 859–869 (2002)

    Article  CAS  Google Scholar 

  21. Ohbayashi, N. et al. FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis. Genes Dev. 16, 870–879 (2002)

    Article  CAS  Google Scholar 

  22. Kronenberg, H. M. PTHrP and skeletal development. Ann. NY Acad. Sci. 1068, 1–13 (2006)

    Article  CAS  ADS  Google Scholar 

  23. Murakami, S. et al. Constitutive activation of MEK1 in chondrocytes causes Stat1-independent achondroplasia-like dwarfism and rescues the Fgfr3-deficient mouse phenotype. Genes Dev. 18, 290–305 (2004)

    Article  CAS  Google Scholar 

  24. Fenichel, I., Evron, Z. & Nevo, Z. The perichondrial ring as a reservoir for precartilaginous cells. In vivo model in young chicks’ epiphysis. Int. Orthop. 30, 353–356 (2006)

    Article  Google Scholar 

  25. Robinson, D. et al. Fibroblast growth factor receptor-3 as a marker for precartilaginous stem cells. Clin. Orthop. Relat. Res. S163–S175 (1999)

    Article  Google Scholar 

  26. Rodríguez, J. I., Delgado, E. & Paniagua, R. Changes in young rat radius following excision of the perichondrial ring. Calcif. Tissue Int. 37, 677–683 (1985)

    Article  Google Scholar 

  27. Bard-Chapeau, E. A. et al. Ptpn11/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesis. Cancer Cell 19, 629–639 (2011)

    Article  CAS  Google Scholar 

  28. Hatakeyama, M. Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nature Rev. Cancer 4, 688–694 (2004)

    Article  CAS  Google Scholar 

  29. Soriano, P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nature Genet. 21, 70–71 (1999)

    Article  CAS  Google Scholar 

  30. Srinivas, S. et al. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev. Biol. 1, 4 (2001)

    Article  CAS  Google Scholar 

  31. Hidaka, K. et al. Involvement of the phosphoinositide 3-kinase/protein kinase B signaling pathway in insulin/IGF-I-induced chondrogenesis of the mouse embryonal carcinoma-derived cell line ATDC5. Int. J. Biochem. Cell Biol. 33, 1094–1103 (2001)

    Article  CAS  Google Scholar 

  32. Mohi, M. G. et al. Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (PTPN11) mutations. Cancer Cell 7, 179–191 (2005)

    Article  CAS  Google Scholar 

  33. Pretzel, D. et al. Relative percentage and zonal distribution of mesenchymal progenitor cells in human osteoarthritic and normal cartilage. Arthritis Res. Ther. 13, R64 (2011)

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank S. Kato for Ctsk-Cre mice, A. Craft for review of the manuscript, X. Wang and P. Monfils for help with histology and J. Cao for helping with μ-CT analysis. This publication was made possible by the National Institutes of Health (NIH) and the National Institute for General Medicine Sciences (NIGMS) grant no. 8P20GM103468. This work was also funded by NIH R21AR57156 (to W.Y.) and R37CA49152 (to B.G.N.), the Rhode Island Hospital Orthopaedic Foundation and a grant from the Pediatric Orthopaedic Society of North America and the Orthopaedic Research and Education Foundation (to W.Y.). B.G.N. is a Canada Research Chair, Tier 1, and is also supported in part by the Ontario Ministry of Health and Long Term Care and the Princess Margaret Cancer Foundation.

Author information

Authors and Affiliations

Authors

Contributions

W.Y. and B.G.N. conceived the project. J.W., D.M., H.L. and W.Y. carried out most of the experiments. M.D. and W.Y. conducted FACS sorting and analysis. H.L. performed the SMOi animal treatment experiment. J.W. performed gene expression and western blot analysis. M.D. and J.W. carried out bone marrow transplantation experiments with the advice of P.J.Q. M.D., H.L. and W.Y. performed CPC multi-lineage differentiation assays. Q.W. and R.T. performed histological staining and data interpretation. Q.C. and M.G.E. provided technical and intellectual support. W.Y. and B.G.N. analysed the data and wrote the manuscript with the help of all authors.

Corresponding author

Correspondence to Wentian Yang.

Ethics declarations

Competing interests

W.Y. and B.G.N. have filed a provisional patent application on the use of Smoothened inhibitors for the treatment of metachondromatosis (Title: Hedgehog Pathway Inhibition for Cartilage Tumor and Metachondromatosis Treatment; UPA#61/614,449)

Supplementary information

Supplementary Figures

This file contains Supplementary Figures 1-9. (PDF 760 kb)

Improved Joint Function in Ctsk-KO

Video clips 1 and 2 show that Ctsk-KO mice treated with SMOi, but not Vehicle, have dramatically improved joint function. In each clip, one mouse is wild type, one is a Ctsk-KO mouse treated with SMOi, and the third is Ctsk-KO mouse treated with vehicle alone. SMOi treatment of Control mice has no apparent effect on mobility. (MOV 23455 kb)

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yang, W., Wang, J., Moore, D. et al. Ptpn11 deletion in a novel progenitor causes metachondromatosis by inducing hedgehog signalling. Nature 499, 491–495 (2013). https://doi.org/10.1038/nature12396

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nature12396

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer